悦心健康
(002162)
| 流通市值：33.24亿 | | | 总市值：33.29亿 |
| 流通股本：9.18亿 | | | 总股本：9.20亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 770,415,368.53 | 508,629,451.72 | 210,618,689.84 | 1,061,871,436.31 |
| 营业收入 | 770,415,368.53 | 508,629,451.72 | 210,618,689.84 | 1,061,871,436.31 |
| 利息收入 | - | 0 | 0 | - |
| 已赚保费 | - | 0 | 0 | - |
| 手续费及佣金收入 | - | 0 | 0 | - |
| 二、营业总成本 | 767,012,404.07 | 496,476,436.77 | 210,377,083.24 | 1,054,181,699.28 |
| 营业成本 | 587,154,743.69 | 379,647,169 | 154,823,720.6 | 813,655,581.55 |
| 利息支出 | - | 0 | 0 | - |
| 手续费及佣金支出 | - | 0 | 0 | - |
| 退保金 | - | 0 | 0 | - |
| 赔付支出净额 | - | 0 | 0 | - |
| 提取保险合同准备金净额 | - | 0 | 0 | - |
| 保单红利支出 | - | 0 | 0 | - |
| 分保费用 | - | 0 | 0 | - |
| 税金及附加 | 8,522,888.65 | 5,920,469.1 | 2,826,212.5 | 11,168,355.23 |
| 销售费用 | 86,771,114.06 | 56,420,905 | 26,578,861.77 | 139,462,220.36 |
| 管理费用 | 67,761,118.66 | 43,815,699.33 | 21,180,671.07 | 65,769,064.86 |
| 研发费用 | 4,097,099.27 | 2,243,421.12 | 824,511.42 | 6,164,479.84 |
| 财务费用 | 12,705,439.74 | 8,428,773.22 | 4,143,105.88 | 17,961,997.44 |
| 其中:利息费用 | 14,474,182.64 | 9,353,819.09 | 4,604,729.4 | 21,844,269.22 |
| 其中:利息收入 | 2,507,085.48 | 1,459,158.04 | 720,867.12 | 4,457,137.59 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,137,100 | 2,137,100 | 0 | 4,791,700 |
| 加:投资收益 | 3,964,700.74 | -516,123.3 | -808,868.35 | 1,458,303.05 |
| 净敞口套期收益 | - | 0 | - | - |
| 汇兑收益 | - | - | 0 | - |
| 资产处置收益 | 515,042.35 | 1,036,246.33 | 1,120,636.26 | -1,966,709.33 |
| 资产减值损失(新) | -9,351,330.31 | -10,968,749.88 | -4,212,557.9 | -11,337,879.63 |
| 信用减值损失(新) | 4,793,241.03 | 4,793,241.03 | 0 | 4,143,012.26 |
| 其他收益 | 1,274,342.88 | 1,212,186.9 | 1,159,581.9 | 3,035,349.58 |
| 四、营业利润 | 6,736,061.15 | 9,846,916.03 | -2,499,601.49 | 7,813,512.96 |
| 加:营业外收入 | 709,740.29 | 482,492.91 | 12,680 | 2,823,541.6 |
| 减:营业外支出 | 337,593.48 | 1,860,553.74 | 35,770.07 | 1,524,908.76 |
| 五、利润总额 | 7,108,207.96 | 8,468,855.2 | -2,522,691.56 | 9,112,145.8 |
| 减:所得税费用 | 1,514,620.18 | 1,286,181.64 | 598,740.1 | 3,138,230.24 |
| 六、净利润 | 5,593,587.78 | 7,182,673.56 | -3,121,431.66 | 5,973,915.56 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 5,593,587.78 | 7,182,673.56 | -3,121,431.66 | 6,520,725.62 |
| 终止经营净利润 | 0 | 0 | 0 | -546,810.06 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,879,943.02 | 5,331,005.23 | -3,366,972.78 | 6,727,107.03 |
| 少数股东损益 | 1,713,644.76 | 1,851,668.33 | 245,541.12 | -753,191.47 |
| 扣除非经常损益后的净利润 | -6,373,099.76 | 844,138.27 | -5,147,111.04 | -13,314,235.14 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0 | 0.01 | 0 | 0.01 |
| (二)稀释每股收益 | 0 | 0.01 | 0 | 0.01 |
| 八、其他综合收益 | - | 0 | 0 | - |
| 归属于母公司股东的其他综合收益 | - | 0 | 0 | - |
| 九、综合收益总额 | 5,593,587.78 | 7,182,673.56 | -3,121,431.66 | 5,973,915.56 |
| 归属于母公司股东的综合收益总额 | 3,879,943.02 | 5,331,005.23 | -3,366,972.78 | 6,727,107.03 |
| 归属于少数股东的综合收益总额 | 1,713,644.76 | 1,851,668.33 | 245,541.12 | -753,191.47 |
| 公告日期 | 2026-10-24 | 2026-07-31 | 2026-04-22 | 2026-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |